𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Convergent pathogenic pathways in Alzheimer's and Huntington's diseases: shared targets for drug development

✍ Scribed by Ehrnhoefer, Dagmar E.; Wong, Bibiana K. Y.; Hayden, Michael R.

Book ID
120324676
Publisher
Nature Publishing Group
Year
2011
Tongue
English
Weight
968 KB
Volume
10
Category
Article
ISSN
1474-1776

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Cholinergic abnormalities in Alzheimer's
Cholinergic abnormalities in Alzheimer's disease: are there new targets for drug development?
✍ Lisa R. Fodero; David H. Small πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 167 KB πŸ‘ 1 views

## Abstract Alzheimer's disease (AD) is a neurodegenerative disease characterized by cognitive impairment and behavioral changes. Cholinesterase inhibitors are currently the drugs of choice for the treatment of AD. However, alternatives to cholinesterase inhibitors such as muscarinic and nicotinic